CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
The new online Learning Center with new content can still be found under the “Training” folder on ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...